ZYXI - Zynex Inc Stock Price, Fair Value and News

11.96USD+0.05 (+0.42%)Market Closed

Market Summary

USD11.96+0.05

Market Closed

0.42%

ZYXI Stock Price

View Fullscreen

ZYXI RSI Chart

ZYXI Valuation

Market Cap

384.8M

Price/Earnings (Trailing)

39.54

Price/Sales (Trailing)

2.09

EV/EBITDA

27.53

Price/Free Cashflow

23.25

ZYXI Price/Sales (Trailing)

ZYXI Profitability

EBT Margin

6.82%

Return on Equity

21.1%

Return on Assets

7.11%

Free Cashflow Yield

4.3%

ZYXI Fundamentals

ZYXI Revenue

Revenue (TTM)

184.3M

Rev. Growth (Yr)

-3.11%

Rev. Growth (Qtr)

-5.27%

ZYXI Earnings

Earnings (TTM)

9.7M

Earnings Growth (Yr)

-83.7%

Earnings Growth (Qtr)

-66.19%

Breaking Down ZYXI Revenue

Last 7 days

-4.8%

Last 30 days

-4.7%

Last 90 days

20.4%

Trailing 12 Months

0.2%

How does ZYXI drawdown profile look like?

ZYXI Financial Health

Current Ratio

4.74

Debt/Equity

1.24

Debt/Cashflow

0.31

ZYXI Investor Care

Buy Backs (1Y)

12.19%

Diluted EPS (TTM)

0.27

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	169.3M	177.4M	185.8M	184.3M
2022	137.3M	143.0M	149.7M	158.2M
2021	89.0M	100.8M	115.5M	130.3M
2020	51.5M	60.5M	68.7M	80.1M
2019	34.2M	37.0M	40.6M	45.5M
2018	26.9M	29.4M	30.7M	31.9M
2017	13.3M	15.0M	18.2M	23.4M
2016	11.9M	12.1M	13.1M	13.3M
2015	11.1M	12.9M	11.1M	11.6M
2014	17.2M	13.1M	12.3M	11.1M
2013	38.4M	33.9M	29.0M	21.7M
2012	36.5M	38.1M	38.8M	39.7M
2011	26.6M	29.1M	31.6M	34.1M
2010	0	0	0	24.1M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Zynex Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 25, 2024	lucsok anna	sold (taxes)	-97,741	12.74	-7,672	chief operating officer
Mar 25, 2024	sandgaard thomas	sold (taxes)	-28,894	12.74	-2,268	president, ceo and chairman
Mar 25, 2024	moorhead daniel j	sold (taxes)	-77,510	12.74	-6,084	chief financial officer
Mar 05, 2024	moorhead daniel j	acquired	-	-	5,000	chief financial officer
Jan 27, 2024	lucsok anna	acquired	-	-	5,000	chief operating officer
Dec 05, 2023	moorhead daniel j	acquired	-	-	5,000	chief financial officer
Oct 27, 2023	sandgaard thomas	acquired	-	-	9,178	president, ceo and chairman
Oct 27, 2023	lucsok anna	acquired	-	-	8,671	chief operating officer
Oct 27, 2023	moorhead daniel j	acquired	-	-	9,178	chief financial officer
Oct 16, 2023	sandgaard thomas	acquired	41,800	0.2	209,000	president, ceo and chairman

Which funds bought or sold ZYXI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 12, 2024	Bridge City Capital, LLC	added	4.05	355,435	2,309,050	0.84%
Apr 11, 2024	Radnor Capital Management, LLC	unchanged	-	20,000	168,000	0.03%
Apr 11, 2024	CONGRESS ASSET MANAGEMENT CO /MA	added	1.05	188,537	1,464,310	0.01%
Apr 11, 2024	Fortitude Family Office, LLC	new	-	10,589	10,589	0.01%
Apr 05, 2024	CWM, LLC	added	160	-	-	-%
Apr 05, 2024	GAMMA Investing LLC	unchanged	-	146	3,414	-%
Apr 03, 2024	WealthCollab, LLC	new	-	2,277	2,277	-%
Mar 22, 2024	PNC Financial Services Group, Inc.	sold off	-100	-10,592	-	-%
Mar 11, 2024	VANGUARD GROUP INC	reduced	-1.31	3,287,530	12,861,000	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	170	2,256,020	3,097,880	-%

Are Funds Buying or Selling ZYXI?

Are funds buying ZYXI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ZYXI

No. of Funds

Unveiling Zynex Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Oct 06, 2023	blackrock inc.	4.1%	1,477,842	SC 13G/A
May 24, 2023	sandgaard thomas	44.6%	16,331,423	SC 13D/A
Feb 01, 2023	blackrock inc.	9.1%	3,396,632	SC 13G/A
Feb 07, 2022	blackrock inc.	8.7%	3,035,364	SC 13G/A
Feb 02, 2021	blackrock inc.	8.3%	2,900,347	SC 13G
Dec 02, 2020	sandgaard thomas	43.66%	15,281,821	SC 13D/A
Jul 20, 2020	sandgaard thomas	36.5%	15,256,642	SC 13D/A
Mar 04, 2020	sandgaard thomas	42.84%	16,631,392	SC 13D/A

Recent SEC filings of Zynex Inc

View All Filings

Date Filed	Form Type	Document
Apr 12, 2024	DEFA14A	DEFA14A
Apr 01, 2024	DEF 14A	DEF 14A
Mar 26, 2024	4	Insider Trading
Mar 26, 2024	4	Insider Trading
Mar 26, 2024	4	Insider Trading
Mar 12, 2024	10-K	Annual Report
Mar 06, 2024	4	Insider Trading
Feb 29, 2024	8-K	Current Report
Jan 29, 2024	4	Insider Trading

Peers (Alternatives to Zynex Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	188.9B	40.1B	-5.73%	4.72%	33.01	4.71	-8.12%	-17.45%
BDX	67.8B	19.5B	-0.88%	-8.17%	53.97	3.48	4.02%	-22.04%
ALGN	22.9B	3.9B	-3.10%	-11.00%	51.41	5.92	3.42%	23.09%
BAX	20.3B	14.8B	-3.77%	-6.99%	7.66	1.37	2.12%	209.17%
MID-CAP
ATR	9.1B	3.5B	-1.99%	15.94%	32.07	2.62	4.97%	18.89%
HSIC	9.1B	12.3B	-5.16%	-14.19%	21.85	0.74	-2.44%	-22.68%
BIO	8.8B	2.7B	-9.88%	-37.29%	-13.77	3.29	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.94%	-24.93%	-47.62	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-0.71%	17.46%	-565.84	9.37	33.86%	89.83%
PDCO	2.3B	6.6B	-6.94%	-4.63%	11.73	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-3.79%	-17.24%	-1.94	0.41	7.73%	-1066.14%
ANIK	376.4M	166.7M	-0.35%	-8.55%	-4.55	2.26	6.67%	-456.34%
ANGO	253.5M	324.0M	17.88%	-30.36%	-1.32	0.78	-3.19%	-337.41%
APYX	47.8M	52.3M	-22.91%	-54.00%	-2.55	0.91	17.61%	19.28%
AEMD	3.8M	3.7M	-16.18%	262.50%	-0.31	1.01	5.77%	8.23%

Zynex Inc News

Latest updates

Zynex Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-5.3%	47.00	50.00	45.00	42.00	49.00	42.00	37.00	31.00	40.00	35.00	31.00	24.00	26.00	20.00	19.00	15.00	14.00	12.00	10.00	9.00	9.00
Costs and Expenses	1.3%	45.00	44.00	42.00	42.00	39.00	35.00	32.00	29.00	29.00	27.00	27.00	25.00	23.00	19.00	15.00	13.00	10.00	9.00	8.00	7.00	6.00
S&GA Expenses	-2.1%	22.00	22.00	22.00	21.00	19.00	17.00	16.00	14.00	14.00	13.00	14.00	14.00	12.00	9.00	7.00	6.00	5.00	4.00	3.00	2.00	2.00
EBITDA Margin	-34.2%	0.08*	0.12*	0.13*	0.14*	0.15*	0.17*	0.19*	0.20*	0.19*	0.13*	0.08*	0.09*	-	-	-	-	-	-	-	-	-
Interest Expenses	100.0%	-	-0.33	-0.32	-0.08	-0.09	-0.11	-0.11	-0.12	-0.02	-0.02	-0.04	-0.01	0.00	0.00	0.00	0.00	-0.01	0.00	-	-	-0.15
Income Taxes	3.2%	1.00	1.00	1.00	0.00	2.00	1.00	1.00	1.00	3.00	2.00	1.00	-0.38	0.00	0.00	1.00	-0.50	1.00	0.00	0.00	1.00	0.00
Earnings Before Taxes	-61.0%	2.00	5.00	4.00	2.00	10.00	6.00	4.00	2.00	12.00	8.00	4.00	-1.09	2.00	1.00	4.00	2.00	4.00	2.00	3.00	3.00	3.00
EBT Margin	-37.7%	0.07*	0.11*	0.12*	0.13*	0.14*	0.16*	0.18*	0.18*	0.17*	0.11*	0.06*	0.07*	-	-	-	-	-	-	-	-	-
Net Income	-66.2%	1.00	4.00	3.00	2.00	7.00	5.00	3.00	1.00	9.00	6.00	3.00	-0.71	2.00	1.00	3.00	3.00	3.00	2.00	2.00	2.00	3.00
Net Income Margin	-38.6%	0.05*	0.09*	0.10*	0.10*	0.11*	0.12*	0.14*	0.14*	0.13*	0.09*	0.05*	0.06*	-	-	-	-	-	-	-	-	-
Free Cashflow	-35.2%	6.00	9.00	1.00	2.00	5.00	7.00	-0.32	2.00	7.00	4.00	1.00	-5.60	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-9.6%	137	151	153	111	116	115	120	132	133	91.00	84.00	70.00	72.00	65.00	37.00	33.00	28.00	25.00	22.00	19.00	19.00
Current Assets	-14.6%	88.00	103	108	65.00	70.00	67.00	71.00	82.00	83.00	70.00	62.00	61.00	63.00	58.00	30.00	26.00	23.00	19.00	16.00	14.00	14.00
Cash Equivalents	4.8%	45.00	43.00	59.00	17.00	20.00	24.00	27.00	39.00	43.00	35.00	32.00	33.00	39.00	41.00	17.00	15.00	14.00	12.00	10.00	9.00	10.00
Inventory	-7.6%	13.00	14.00	14.00	14.00	13.00	14.00	15.00	13.00	11.00	9.00	10.00	11.00	9.00	6.00	5.00	3.00	2.00	2.00	1.00	2.00	1.00
Net PPE	26.2%	3.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Goodwill	0%	20.00	20.00	20.00	20.00	20.00	20.00	20.00	20.00	20.00	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	-2.2%	91.00	93.00	90.00	47.00	50.00	50.00	51.00	56.00	59.00	27.00	26.00	14.00	15.00	11.00	10.00	10.00	9.00	8.00	8.00	7.00	10.00
Current Liabilities	-6.6%	19.00	20.00	14.00	21.00	21.00	20.00	19.00	22.00	23.00	10.00	9.00	9.00	10.00	7.00	6.00	6.00	5.00	5.00	4.00	4.00	7.00
Short Term Borrowings	-	-	-	-	5.00	5.00	5.00	5.00	-	5.00	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt	-100.0%	-	57.00	57.00	4.00	-	7.00	8.00	9.00	11.00	-	-	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	0.4%	58.00	57.00	57.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-21.3%	46.00	59.00	62.00	64.00	66.00	65.00	69.00	76.00	74.00	63.00	57.00	56.00	57.00	54.00	27.00	23.00	20.00	16.00	14.00	12.00	9.00
Retained Earnings	4.8%	27.00	26.00	22.00	19.00	17.00	10.00	5.00	1.00	-	32.00	26.00	23.00	23.00	22.00	20.00	17.00	14.00	11.00	9.00	7.00	5.00
Additional Paid-In Capital	0.4%	91.00	91.00	83.00	82.00	82.00	82.00	81.00	81.00	80.00	38.00	38.00	37.00	37.00	36.00	11.00	10.00	9.00	9.00	9.00	8.00	8.00
Shares Outstanding	-3.8%	33.00	34.00	36.00	37.00	37.00	38.00	39.00	40.00	40.00	38.00	38.00	38.00	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09
Float	-	-	-	-	-	-	-	175	-	-	-	308	-	-	-	422	-	-	-	292	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-30.4%	6,188	8,893	741	1,934	4,757	7,411	-176	1,754	7,538	3,689	1,027	-5,305	-1,696	-769	2,651	632	2,098	1,841	600	1,764	2,641
Share Based Compensation	3.2%	675	654	660	307	640	578	535	589	588	533	401	108	875	730	579	497	264	258	158	140	-
Cashflow From Investing	194.2%	9,424	-10,006	-210	-174	-86.00	-120	-140	-72.00	-16,186	-66.00	-55.00	-299	-226	-105	-357	-297	-28.00	9.00	-95.00	-46.00	-191
Cashflow From Financing	10.4%	-13,550	-15,119	41,426	-5,112	-8,059	-10,636	-12,054	-5,047	15,892	-585	-2,081	-130	-134	25,187	37.00	210	36.00	30.00	130	-2,427	-418
Dividend Payments	-	2.00	-	-	-	-	-	-	3,613	1.00	-	-	-	-	-	-	-	-	3.00	-	2,259	-
Buy Backs	-6.2%	14,003	14,934	6,115	3,353	6,615	9,156	10,655	-	-1,039	547	2,045	75.00	-	-	-	-	-	-	-	171	387

ZYXI Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
NET REVENUE
Total net revenue	$ 184,322	$ 158,167
COSTS OF REVENUE AND OPERATING EXPENSES
Costs of revenue - devices and supplies	38,366	32,005
Sales and marketing	86,659	67,116
General and administrative	48,517	36,108
Total costs of revenue and operating expenses	173,542	135,229
Income from operations	10,780	22,938
Other income (expense)
Gain on sale of fixed assets	39
Gain (loss) on change in fair value of contingent consideration	2,854	(300)
Interest expense, net	(1,094)	(440)
Other income (expense), net	1,799	(740)
Income from operations before income taxes	12,579	22,198
Income tax expense	2,847	5,150
Net income	$ 9,732	$ 17,048
Net income per share:
Basic	$ 0.27	$ 0.44
Diluted	$ 0.27	$ 0.44
Weighted average basic shares outstanding	35,555,000	38,467,000
Weighted average diluted shares outstanding	36,142,000	39,127,000
Devices
NET REVENUE
Total net revenue	$ 58,822	$ 43,497
Supplies
NET REVENUE
Total net revenue	$ 125,500	$ 114,670

ZYXI Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 44,579	$ 20,144
Accounts receivable, net	26,838	35,063
Inventory, net	13,106	13,484
Prepaid expenses and other	3,332	868
Total current assets	87,855	69,559
Property and equipment, net	3,114	2,175
Operating lease asset	12,515	12,841
Finance lease asset	587	270
Deposits	409	591
Intangible assets, net of accumulated amortization	8,158	9,067
Goodwill	20,401	20,401
Deferred income taxes	3,865	1,562
Total assets	136,904	116,466
Current liabilities:
Accounts payable and accrued expenses	8,433	5,617
Operating lease liability	3,729	2,476
Finance lease liability	196	128
Income taxes payable	633	1,995
Current portion of debt		5,333
Accrued payroll and related taxes	5,541	5,537
Total current liabilities	18,532	21,086
Long-term liabilities:
Long-term portion of debt, less issuance costs		5,293
Convertible senior notes, less issuance costs	57,605
Contingent consideration		10,000
Operating lease liability	14,181	13,541
Finance lease liability	457	188
Total liabilities	90,775	50,108
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of December 31, 2023 and December 31, 2022
Common stock, $0.001 par value; 100,000,000 shares authorized; 41,980,166 issued and 32,933,776 outstanding as of December 31, 2023, 41,658,132 issued and 36,825,081 outstanding as of December 31, 2022	33	39
Additional paid-in capital	90,878	82,431
Treasury stock of 8,545,044 and 4,253,015 shares at December 31, 2023 and December 31, 2022, respectively, at cost	(71,562)	(33,160)
Retained earnings	26,780	17,048
Total stockholders' equity	46,129	66,358
Total liabilities and stockholders' equity	$ 136,904	$ 116,466

About Zynex Inc

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

CEO	Mr. Thomas Sandgaard
WEBSITE	zynex.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	900

Zynex Inc Frequently Asked Questions

What is the ticker symbol for Zynex Inc? What does ZYXI stand for in stocks?

ZYXI is the stock ticker symbol of Zynex Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zynex Inc (ZYXI)?

As of Mon Apr 15 2024, market cap of Zynex Inc is 384.76 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZYXI stock?

You can check ZYXI's fair value in chart for subscribers.

What is the fair value of ZYXI stock?

You can check ZYXI's fair value in chart for subscribers. The fair value of Zynex Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Zynex Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ZYXI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Zynex Inc a good stock to buy?

The fair value guage provides a quick view whether ZYXI is over valued or under valued. Whether Zynex Inc is cheap or expensive depends on the assumptions which impact Zynex Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZYXI.

What is Zynex Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, ZYXI's PE ratio (Price to Earnings) is 39.54 and Price to Sales (PS) ratio is 2.09. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZYXI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zynex Inc's stock?

In the past 10 years, Zynex Inc has provided 0.438 (multiply by 100 for percentage) rate of return.